GKB Ophthalmics

72.39
+0.66
(0.92%)
Market Cap
36.53 Cr
EPS
-5.58
PE Ratio
-
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
136.40
52 Week Low
59.00
PB Ratio
0.62
Debt to Equity
0.19
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
2,393.50
#1 24,252.31
74.60
#1 1,434.50
24.59
#1 258
#1 31.08
61.57
395.30
2,103.24
71.13
307.90
-0.45
43
-46.46
66.87
526.00
631.40
36.20
59.30
30.58
16
25.00
62.97
248.16
248.16
-
102.40
-13.51
-2
-1,500.00
60.69
245.00
131.13
79.33
17.80
#1 136.23
2
-98.33
61.41
105.50
110.17
#1 11.35
109.90
-1.43
10
-
51.40
134.50
49.07
49.19
51.30
-2.84
1
-400.00
64.43
125.00
41.30
82.78
14.00
27.27
1
-
84.07
45.90
39.70
20.77
32.30
14.13
3
0.50
52.47
72.39
#10 36.53
-
#5 89.80
#5 17.54
#10 -3
#4 -35.71
52.81
Growth Rate
Revenue Growth
17.54 %
Net Income Growth
-3,100.00 %
Cash Flow Change
252.35 %
ROE
-2,829.41 %
ROCE
-150.20 %
EBITDA Margin (Avg.)
-61.53 %

Quarterly Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
16
15
12
17
13
14
16
16
7
16
17
19
16
19
20
18
18
19
19
20
23
21
24
22
26
26
26
Expenses
15
14
13
15
13
14
15
15
8
15
16
17
14
18
18
16
15
17
19
20
21
21
25
22
25
26
27
EBITDA
1
1
-1
3
1
-0
1
1
-1
1
2
2
1
1
2
2
3
2
-0
-0
2
0
-0
1
1
0
-1
Operating Profit %
4 %
4 %
-7 %
2 %
3 %
-2 %
7 %
5 %
-12 %
4 %
7 %
2 %
8 %
3 %
8 %
9 %
15 %
8 %
-0 %
-2 %
6 %
-1 %
-3 %
0 %
4 %
-0 %
-4 %
Depreciation
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
0
0
0
2
1
1
1
1
1
1
1
Interest
0
0
0
0
0
0
0
1
0
0
1
0
0
0
0
0
0
1
0
0
0
1
0
1
1
1
1
Profit Before Tax
-0
-0
-2
1
-1
-1
-0
-0
-2
-0
-0
1
0
-0
1
1
2
1
-1
-2
1
-1
-1
-1
0
-1
-2
Tax
-0
0
0
-1
-0
-0
-0
-0
-0
-0
-0
-0
0
0
0
-0
-0
0
0
-0
0
0
0
0
-0
0
0
Net Profit
-0
-0
-2
2
-1
-1
0
-0
-2
-0
0
1
0
-0
1
1
2
1
-1
-2
1
-1
-1
-1
0
-1
-2
EPS in ₹
-1.16
-0.56
-4.46
2.96
-1.55
-2.59
0.01
-0.66
-3.68
-0.50
0.16
2.23
0.27
-0.67
1.63
1.29
3.84
1.68
-2.05
-3.80
1.04
-2.32
-2.48
-1.81
-0.50
-2.41
-4.03

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
75
69
82
83
93
102
107
110
112
115
Fixed Assets
12
13
18
18
26
26
24
23
19
18
Current Assets
46
51
63
64
64
73
74
76
84
88
Capital Work in Progress
1
1
1
0
0
0
1
3
4
4
Investments
0
6
4
0
1
1
2
2
2
2
Other Assets
63
50
60
64
67
75
80
82
87
91
Total Liabilities
75
69
82
83
93
102
107
110
112
115
Current Liabilities
33
23
33
36
37
41
38
39
41
46
Non Current Liabilities
2
2
2
2
2
2
2
4
4
4
Total Equity
40
45
47
45
55
59
66
67
67
64
Reserve & Surplus
36
41
43
41
47
54
58
58
58
55
Share Capital
4
4
4
4
5
5
5
5
5
5

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
1
0
-1
0
7
4
-7
-0
-4
1
Investing Activities
-1
15
4
1
-10
-4
-17
-4
1
-2
Operating Activities
7
-11
-3
-3
4
3
7
5
-3
4
Financing Activities
-6
-3
-1
1
13
4
3
-2
-2
-2

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
59.44 %
59.24 %
59.58 %
59.69 %
59.72 %
59.73 %
59.16 %
59.09 %
59.09 %
59.18 %
50.86 %
50.88 %
50.93 %
50.95 %
50.95 %
50.98 %
50.99 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
1.79 %
1.79 %
1.79 %
1.79 %
1.79 %
1.79 %
1.79 %
DIIs
0.39 %
0.39 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
23.93 %
24.44 %
24.90 %
24.48 %
24.63 %
24.79 %
24.82 %
24.79 %
27.11 %
27.40 %
36.01 %
36.04 %
36.04 %
36.64 %
36.34 %
36.96 %
37.36 %
Others
16.24 %
15.93 %
15.52 %
15.83 %
15.65 %
15.47 %
16.01 %
16.11 %
13.79 %
13.41 %
11.34 %
11.28 %
11.23 %
10.63 %
10.93 %
10.27 %
9.87 %
No of Share Holders
1,185
1,545
1,430
1,434
1,432
1,443
1,443
1,637
1,933
2,030
2,115
2,233
2,370
2,690
2,510
2,539
2,538

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Announcements

Non Applicability Of Circular No. SEBI/HO/DDHS/CIR/P/2018/144 Dated November 26 2018.9 days ago
Announcement under Regulation 30 (LODR)-Credit Rating10 days ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2025
Disclosure Under Regulations 31 (4) Of SEBI (Substantial Acquisition Of Shares And Takeover) Regulations 2011 For The Financial Year Ended On March 31 2025.Apr 02, 2025
Disclosure Under Regulations 31 (4) Of SEBI (Substantial Acquisition Of Shares And Takeover) Regulations 2011 For The Financial Year Ended On March 31 2025.Apr 02, 2025
Intimation Under Regulation 30 Of SEBI( Listing Obligations And Disclosure Requirements) Regulation 2015- Completion Of Tenure Of Independent Director And Re- Constitution Of Committees Of The Board.Mar 31, 2025
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015Mar 31, 2025
Closure of Trading WindowMar 29, 2025
Outcome Of Independent Directors Meeting Held On March 27 2025.Mar 27, 2025
Notice Of The Independent Directors MeetingMar 18, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 19, 2025
Integrated Filing (Financial)Feb 13, 2025
GKB- Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31 2024Feb 13, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Of GKB Ophthalmics Limited Held On February 13 2025Feb 13, 2025
GKB Ophthalmics Limited Integrated Filling(Governance) For The Quarter Ended December 31 2024Feb 06, 2025
Board Meeting Intimation for Consider And Take On Record The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2024.Jan 24, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 09, 2025
Change In Name Of Registrar And Share Transfer Agent("RTA")Jan 09, 2025
Outcome Of The Board Meeting Held On January 03 2025 And Execution Of Loan AgreementJan 03, 2025
Sanctioning Of Loan Amount Of Rs. 5.00 Crores By Subsidiary Company To GKB Ophthalmics Limited Holding Company.Jan 02, 2025
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015Dec 31, 2024
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015Dec 31, 2024
Closure of Trading WindowDec 27, 2024
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015Dec 04, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 18, 2024
Submission Of Consolidated Related Party Transaction As On September 30, 2024Nov 14, 2024
Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2024.Nov 14, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held On November 14, 2024 To Take On Record The Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2024.Nov 14, 2024
Board Meeting Intimation for Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2024Oct 30, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 24, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 09, 2024
Closure of Trading WindowSep 27, 2024
Submission Of Minutes Of 42Nd Annual General Meeting Of The Company Held On 20Th August , 2024.Sep 05, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateSep 02, 2024
Outcome Of The Board Meeting Held On August 31, 2024 And Signing Of Loan AgreementAug 31, 2024
Scrutinizer''s Report_Voting Results Of The Annual General Meeting Held On August 20, 2024Aug 21, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMAug 20, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 19, 2024
Statement Of Deviation(S) Or Variation(S) Under Regulation 32 Of SEBI ( Listing Obligations And Disclosure Requirements) Regulations, 2025 - June 30, 2024Aug 13, 2024
Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2024Aug 13, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Of GKB Ophthalmics Limited Held On August 13, 2024 For Approval Of Unaudited Standalone And Consolidated Financial - Quarter Ended June 30, 2024Aug 13, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 29, 2024
Notice For Book Closure -Annual General Meeting 2023-24.Jul 26, 2024
Reg. 34 (1) Annual Report.Jul 26, 2024
Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended June 30, 2024.Jul 19, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 19, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 06, 2024
Closure of Trading WindowJun 28, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateJun 27, 2024
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015Jun 20, 2024

Technical Indicators

RSI(14)
Neutral
52.81
ATR(14)
Less Volatile
6.02
STOCH(9,6)
Neutral
46.90
STOCH RSI(14)
Overbought
100.00
MACD(12,26)
Bullish
1.21
ADX(14)
Weak Trend
21.40
UO(9)
Bearish
40.93
ROC(12)
Uptrend And Accelerating
7.77
WillR(14)
Neutral
-32.03